Suchergebnisse - "Hynes, Scott M"

PubPharm (40)

1

A Phase 1b trial of prexasertib in combination with chemoradiation in patients with locally advanced head and neck squamous cell carcinoma

enthalten in: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology | 2021

von Yang, E. | Deutsch, E. | Mehmet, A. | +11

2

Disposition of [14C]LY2606368 following intravenous administration in patients with advanced and/or metastatic solid tumours

enthalten in: Xenobiotica; the fate of foreign compounds in biological systems | 2020

von Wickremsinhe, E. | Hynes, S. | Payne, C. | +2

3

Disposition of [14C]LY2606368 following intravenous administration in patients with advanced and/or metastatic solid tumours

enthalten in: Xenobiotica | 2020

von Wickremsinhe, E. | Hynes, S. | Payne, C. | +2

4

Correction to : A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer

enthalten in: Cancer chemotherapy and pharmacology | 2018

von Patnaik, A. | Gordon, M. | Tsai, F. | +11

ErratumFor: Cancer Chemother Pharmacol. 2018 Sep;82(3):407-418. - PMID 29926131

5

A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer

enthalten in: Cancer chemotherapy and pharmacology | 2018

von Patnaik, A. | Gordon, M. | Tsai, F. | +11

ErratumIn: Cancer Chemother Pharmacol. 2018 Jul 16;: Papadopoulous, Kyri [corrected to Papadopoulos, Kyriakos P] and Beeram, S Muralidhar [corrected to Beeram, Muralidhar]. - PMID 30014222

6

Correction to: A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer

enthalten in: Cancer chemotherapy and pharmacology | 2018

von Patnaik, A. | Gordon, M. | Tsai, F. | +11

7

Correction to: A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer

enthalten in: Cancer chemotherapy and pharmacology | 2018

von Patnaik, A. | Gordon, M. | Tsai, F. | +11

8

Correction to: A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer

enthalten in: Cancer chemotherapy and pharmacology | 2018

von Patnaik, A. | Gordon, M. | Tsai, F. | +11

9

A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer

enthalten in: Cancer chemotherapy and pharmacology | 2018

von Patnaik, A. | Gordon, M. | Tsai, F. | +11

10

A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer

enthalten in: Cancer chemotherapy and pharmacology | 2018

von Patnaik, A. | Gordon, M. | Tsai, F. | +11